Promising growth and investment in the cell therapy industry during the first quarter of 2012.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 22560072.
- Also identified by DOI 10.1016/j.stem.2012.04.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress.
Medical subject headings
- Cell Transplantation
- Health Care Sector